PubMed:23242220 / 751-1155
Annnotations
PubMed_Structured_Abstracts
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T3 | 0-404 | CONCLUSIONS | denotes | Detailed studies on the composition of SPA of Babesia canis canis and reactivity of its individual protein fractions can be a starting point for the development of subunit vaccines against babesiosis. Using a preparation with only some electrophoretic fractions of SPA in the production of vaccines would allow to avoid putting an unnecessary protein burden in the vaccine which could cause side effects. |
Goldhamster2_Cellosaurus
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T3 | 124-125 | CVCL_6479|Finite_cell_line|Mus musculus | denotes | a |
T4 | 207-208 | CVCL_6479|Finite_cell_line|Mus musculus | denotes | a |
T5 | 328-330 | CVCL_8754|Cancer_cell_line|Homo sapiens | denotes | an |
T6 | 328-330 | CVCL_H241|Cancer_cell_line|Homo sapiens | denotes | an |
GoldHamster
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T66 | 39-42 | A0A0H3K686 | denotes | SPA |
T67 | 39-42 | PR:000029158 | denotes | SPA |
T68 | 39-42 | PR:P02976 | denotes | SPA |
T69 | 39-42 | PR:P99134 | denotes | SPA |
T70 | 39-42 | P99134 | denotes | SPA |
T71 | 39-42 | PR:Q9USQ5 | denotes | SPA |
T72 | 39-42 | PR:P0A015 | denotes | SPA |
T73 | 39-42 | P02976 | denotes | SPA |
T74 | 39-42 | P38507 | denotes | SPA |
T75 | 39-42 | PR:P38507 | denotes | SPA |
T76 | 39-42 | P0A015 | denotes | SPA |
T78 | 46-59 | 5867 | denotes | Babesia canis |
T83 | 99-106 | SO:0000104 | denotes | protein |
T80 | 99-106 | CHEBI:36080 | denotes | protein |
T81 | 99-106 | CHEBI:11122 | denotes | protein |
T82 | 99-106 | PR:000000001 | denotes | protein |
T79 | 99-106 | GO:0003675 | denotes | protein |
T84 | 164-180 | D022223 | denotes | subunit vaccines |
T85 | 164-180 | D022223 | denotes | subunit vaccines |
T88 | 189-199 | D001404 | denotes | babesiosis |
T89 | 189-199 | D001404 | denotes | babesiosis |
T90 | 265-268 | A0A0H3K686 | denotes | SPA |
T91 | 265-268 | PR:000029158 | denotes | SPA |
T92 | 265-268 | PR:P02976 | denotes | SPA |
T93 | 265-268 | PR:P99134 | denotes | SPA |
T94 | 265-268 | P99134 | denotes | SPA |
T95 | 265-268 | PR:Q9USQ5 | denotes | SPA |
T96 | 265-268 | PR:P0A015 | denotes | SPA |
T97 | 265-268 | P02976 | denotes | SPA |
T98 | 265-268 | P38507 | denotes | SPA |
T99 | 265-268 | PR:P38507 | denotes | SPA |
T100 | 265-268 | P0A015 | denotes | SPA |
T101 | 290-298 | D014612 | denotes | vaccines |
T102 | 290-298 | D014612 | denotes | vaccines |
T106 | 343-350 | PR:000000001 | denotes | protein |
T103 | 343-350 | GO:0003675 | denotes | protein |
T107 | 343-350 | SO:0000104 | denotes | protein |
T104 | 343-350 | CHEBI:36080 | denotes | protein |
T105 | 343-350 | CHEBI:11122 | denotes | protein |